Glycopyrrolate Injection
Product Images NDC 76045-023

11 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 76045-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gly0c 0006 01)

Figure 1 (Gly0c 0006 01)
An instructional diagram showing an outer package containing a syringe with labeled parts. The syringe is identified by components including the plunger rod, syringe barrel, syringe tip cap, luer lock collar (do not remove), and label (do not remove). The image appears to guide on the syringe's assembly or use.*
FDA Label Image

Figure 2 (Gly0c 0006 02)

Figure 2 (Gly0c 0006 02)
An instructional line drawing showing hands peeling the protective cover off a pre-filled syringe package for Glycopyrrolate injection. The image illustrates the initial step of accessing the syringe for intramuscular or intravenous administration.*
FDA Label Image

Figure 3 (Gly0c 0006 03)

Figure 3 (Gly0c 0006 03)
An instructional line drawing showing two hands opening a medical vial or ampule by twisting off the top, indicated by a curved arrow. This diagram likely demonstrates the initial step for preparing an injection, such as glycopyrrolate injection.*
FDA Label Image

Structural Formula (Gly0c 0006 04)

Structural Formula (Gly0c 0006 04)
Chemical structure diagram of Glycopyrrolate, showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*
FDA Label Image

Fresenius Kabi Logo (Gly0c 0006 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Syringe Label)
Glycopyrrolate Injection USP in a 3 mL single-dose prefilled syringe for intramuscular or intravenous use. The label shows a strength of 0.6 mg per 3 mL (0.2 mg/mL) and includes a volume scale from 0.5 mL to 3 mL. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Blister Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Blister Label)
Label for Glycopyrrolate Injection, USP 0.6 mg/3 mL (0.2 mg/mL) in a 3 mL single-dose prefilled syringe. The injection is preservative-free, intended for intramuscular or intravenous use, and manufactured by Fresenius Kabi USA, LLC. Storage and usage instructions are included, along with expiration and lot number fields.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Carton Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Carton Label)
Packaging label for Glycopyrrolate Injection, USP 0.6 mg/3 mL (0.2 mg/mL) by Fresenius Kabi USA, LLC. The label indicates the product is for intramuscular or intravenous use, preservative-free, and supplied as 10 single-dose prefilled syringes of 3 mL each. Storage instructions and a warning not to place the syringe on a sterile field are included.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Syringe Labe)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Syringe Labe)
Label for Glycopyrrolate Injection, USP in a 3 mL single-dose prefilled syringe for intramuscular or intravenous use. The strength is 0.6 mg per 3 mL (0.2 mg/mL). The label includes a volume scale from 0.5 mL to 3 mL, a barcode, and the manufacturer Fresenius Kabi USA, LLC. Lot and expiration placeholders are shown.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Blister Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Blister Label)
Label for Glycopyrrolate Injection, USP at 0.6 mg/3 mL (0.2 mg/mL) strength in a 3 mL single-dose prefilled syringe. The label indicates it is preservative-free and intended for intramuscular or intravenous use. It includes storage instructions, lot number, and expiration date fields. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Carton Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Carton Label)
Packaging label of Glycopyrrolate Injection, USP 0.6 mg/3 mL (0.2 mg/mL) for intramuscular or intravenous use. The label states it is preservative free and contains 10 single-dose prefilled syringes of 3 mL each. Manufacturer is Fresenius Kabi USA, LLC. Warnings include not placing the syringe on a sterile field and instructions to discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.